Document Detail


Continuous monitoring of global left ventricular ejection fraction during percutaneous transluminal coronary angioplasty.
MedLine Citation:
PMID:  9555774     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Continuous monitoring of left ventricular (LV) function during percutaneous transluminal coronary angioplasty (PTCA) was performed in 40 patients (53 +/- 2 years) with a miniature, nuclear detector system after labeling the patients' red blood cells with technetium-99m. Balloon dilation (113 seconds, range 60 to 240) induced on average a 0.12 ejection fraction (EF) unit (19%) decrease in the LVEF, which was explained by a 34% increase in end-systolic counts. Balloon dilation of the left anterior descending artery (n = 23) produced a decrease in the LVEF of 0.17 +/- 0.13 EF units compared with the decrease of 0.06 +/- 0.07 EF units in patients undergoing dilation of the left circumflex artery (n = 9) and 0.05 +/- 0.04 EF units in patients treated for a stenosis of the right coronary artery (n = 8), (p = 0.02). Balloon deflation was associated with an immediate return to pre-PTCA levels. In 10 patients with 2 identical balloon occlusions, the second occlusion led to a significantly less decrease in the LVEF (0.41 +/- 0.14 vs 0.44 +/- 0.15) and electrocardiographic ST-segment deviation (88 +/- 54 microV vs 65 +/- 42 microV) than the first. We conclude that PTCA is associated with an abrupt transient decrease in the LVEF. The effect of balloon occlusion of the left anterior descending artery is more pronounced than balloon occlusion of the left circumflex and the right coronary arteries. Neither single nor multiple balloon occlusions were associated with post-PTCA global LV dysfunction, whereas the lesser degree of LV dysfunction and electrocardiographic signs of myocardial ischemia during the second of 2 identical balloon occlusions suggests that preconditioning can be induced during PTCA.
Authors:
T B Lindhardt; H Kelbaek; J K Madsen; K Saunamäki; P Clemmensen; B Hesse; N Gadsbøll
Related Documents :
10323534 - Balloon valvoplasty in infants with tetralogy of fallot: effects on oxygen saturation a...
16297254 - Follow-up results of cutting balloon angioplasty used to relieve stenoses in small pulm...
12047784 - Continuous ultrasonic monitoring of balloon valvuloplasty.
15996774 - Transient mid-ventricular ballooning cardiomyopathy: a new entity of takotsubo cardiomy...
2961514 - Human atrial natriuretic peptide secretion in precapillary pulmonary hypertension. clin...
470424 - Mustard's operation modified to avoid dysrhythmias and pulmonary and systemic venous ob...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The American journal of cardiology     Volume:  81     ISSN:  0002-9149     ISO Abbreviation:  Am. J. Cardiol.     Publication Date:  1998 Apr 
Date Detail:
Created Date:  1998-05-05     Completed Date:  1998-05-05     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0207277     Medline TA:  Am J Cardiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  853-9     Citation Subset:  AIM; IM    
Affiliation:
Heart Center, Medical Department B, Rigshospitalet, Copenhagen University Hospital, Denmark.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Angioplasty, Transluminal, Percutaneous Coronary*
Coronary Disease / physiopathology,  radionuclide imaging,  therapy*
Electrocardiography
Erythrocytes
Female
Heart / radionuclide imaging*
Humans
Male
Middle Aged
Monitoring, Physiologic / methods
Myocardial Ischemia / physiopathology
Stroke Volume / physiology*
Technetium / diagnostic use
Time Factors
Ventricular Dysfunction, Left / physiopathology
Ventricular Function, Left / physiology*
Chemical
Reg. No./Substance:
7440-26-8/Technetium

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Coronary angioplasty outcomes in the Healthcare Cost and Utilization Project, 1993-1994.
Next Document:  One-year follow-up of the Stent Restenosis (STRESS I) Study.